addressing urgent Healthcare Priorities
Maryland is an innovative leader in vaccine research and development with fully 20 percent of the world’s top influencers in vaccine development in the state. In Montgomery County, find some of the top vaccine companies advancing life-saving vaccines to fight infectious diseases. With one of the largest and most robust life sciences clusters in the nation, Montgomery County is also a prime location with the presence of the NIH, the FDA, and NIST.
Maryland is #1 in NIH Research & Development Contract Awards
Maryland is #1 in Concentration of Employed Doctoral Scientists in MD
91.5% Increase in STEM degrees in the Univ of MD System since 2009
$556 Million in VC investment to MoCo companies Jan to July 2018, with 72% to Biotech companies
MONTGOMERY IS BUILT FOR BIO
Top global life science leaders and emerging companies call Montgomery County home. Our diverse businesses are at the convergence of gene therapy, CAR T-cell therapy, vaccines and other fast-moving discoveries. Find out how Montgomery County, Maryland is #BuiltforBio.
SF OF WET LAB SPACE
OF TOP VACCINE DEVELOPMENT INFLUENCERS ARE IN MD
BIOHEALTH COMPANIES IN MOCO
BIOTECH WORKERS AND 6,000 STEM PHDs IN MOCO
Finding Public Health Solutions
Vaccines are among the most successful and cost-effective public health tools available for preventing disease and death, and they remain the best defense against the flu and several serious diseases like measles and diphtheria. Medical advancements and research have led to the development of vaccinations that protect against dozens of diseases. The numbers tell the story—when immunization rates are high, whole communities around the world are better protected.
Meet Some of the County’s Thriving Vaccine Companies
GlaxoSmithKline (GSK) opened a global vaccines R&D Center in Rockville in 2016. It is a state-of-the-art facility that employs more than 450 scientists and support staff. GSK vaccines run the gamut including childhood vaccines against diseases such as measles, meningitis and pneumonia, helping to protect the developing immune systems of infants and preventing millions of deaths each year.
We are delighted to be opening our new facility in Rockville, GSK’s first fully dedicated vaccines R&D center located in the US. Our investment here signifies our commitment to discovering and developing new vaccines across a range of pressing public health priorities, including those important here in the US. It places GSK at the heart of a dynamic and cutting edge bioscience hub in Washington, D.C.
Altimmune is a clinical stage immunotherapeutic biotech company in Gaithersburg. It has created NasoVAX, a new way to fight the flu, mobilizing the immune system in unconventional ways. It is also developing a NasoShield Anthrax vaccine.
Emergent BioSolutions is based in Gaithersburg, and found growth and new opportunity when it moved to Maryland from another state. Emergent manufactures BioThrax, the only FDA-licensed vaccine to protect against anthrax disease.
Novavax is a clinical stage biotech company in Gaithersburg that delivers products to prevent a range of infection diseases. They use proprietary technology and have a product pipeline targeting a infection diseases including seasonal influenza and Ebola virus.
Synam has a mission to eradicate pneumococcal diseases—from pneumonia, middle ear infections to meningitis—with the world’s first universal vaccine. Its located in the Rockville Innovation Center, an incubator for emerging companies and fitted with wet lab space.
18 Federal Agency Headquarters in Montgomery County
With dozens of Federal research institutes and several top-ranking research universities focusing on vaccine research in the area, it’s no wonder that innovative vaccine research and development has become an important sector in the growing BioHealth presence. Significant vaccine influencers are strong contributors to the field of vaccines and immunization.throughout our region. Proximity to so many potential customers, employees and collaborators is another major advantage for emerging and established companies.
Federal support includes the following:
The National Institutes of Health (NIH), the nation’s medical research agency, making important discoveries that improve health and save lives. NIH encompasses 27 Institutes and Centers.
National Cancer Institute (NCI) is a part of NIH. Located in Rockville, NCI leads the nation’s research efforts to improve cancer prevention, detection, diagnosis, and survivorship. It supports thousands of clinical trials and collaborates with private sector life sciences companies and federal agencies.
Vaccine Research Center (VRC) helps to further research in vaccine development. The VRC is dedicated to improving global human health—and Maryland is a leader in creation and production of effective vaccines for human diseases. VRC is part of the National Institute of Allergy and Infectious Diseases.
The Food and Drug Administration (FDA) protects the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products.
Support Resources in Abundance
BioHealth Innovation (BHI) helps companies commercialize their technologies and advance to market by introducing entrepreneurs to sources of capital and private investment. BHI operates County’s innovation centers/incubators in Rockville and Germantown, co-manages shared lab space in Alexandria LaunchLabs, and assists BioHealth companies seeking to enter the US market with its International Soft-Landing program.
TEDCO helps companies by ‘leading innovation to market.” TEDCO provides resources and connections that early stage technology and life sciences companies need to thrive across Maryland. It has an assessment tool to help define your investment readiness.
BioHealth Incentives and Funding
The County and state both have incentives to explore, including:
Maryland Biotechnology Investment Incentive Tax Credit (BIITC) provides an income tax credit equal to 50% of an eligible investment in a Qualified Maryland Biotechnology Company (QMBC) up to $250,000 for each QMBC per fiscal year.
Venture Capital Funding in Montgomery County helps investors recognize the innovation happening in Montgomery County. From January to July 2018, $556 Million flowed in from venture capital investment dollars to MoCo companies. A strong 72% of the 2018 VC investment has been in the biotech area.
Sanaria is a biotechnology company that is developing vaccines to protect against malaria. The company was the recipient of Montgomery County’s Small Business Awards as its Bioscience Company of the Year in 2015. Sanaria’s vaccines have proven highly protective in humans. One million people die from malaria each year, and children are frequently among the most affected groups.